Stereotaxis, a publicly traded company, is the global leader in innovative robotic technologies designed to enhance the treatment of arrhythmias and perform endovascular procedures. Their mission is the discovery, development and delivery of robotic systems, instruments, and information solutions for the interventional laboratory. These innovations help physicians provide unsurpassed patient care with robotic precision and safety, improved lab efficiency and productivity, and enhanced integration of procedural information.